AHNAKs roles in physiology and malignant tumors
Frontiers in Oncology · 14.11.2023 · 13
DOI: 10.3389/fonc.2023.1258951 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Oncology, online erschienen am 14.11.2023. Verfasst von Shusen Zhang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Hebei Province Xingtai People's Hospital Postdoctoral Workstation, Xingtai, China. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 112 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The AHNAK family currently consists of two members, namely AHNAK and AHNAK2, both of which have a molecular weight exceeding 600 kDa. Homologous sequences account for approximately 90% of their composition, indicating a certain degree of similarity in terms of molecular structure and biological functions. AHNAK family members are involved in the regulation of various biological functions, such as calcium channel modulation and membrane repair. Furthermore, with advancements in biological and bioinformatics technologies, research on the relationship between the AHNAK family and tumors has rapidly increased in recent years, and its regulatory role in tumor progression has gradually been discovered. This article briefly describes the physiological functions of the AHNAK family, and reviews and analyzes the expression and molecular regulatory mechanisms of the AHNAK family in malignant tumors using Pubmed and TCGA databases. In summary, AHNAK participates in various physiological and pathological processes in the human body. In multiple types of cancers, abnormal expression of AHNAK and AHNAK2 is associated with prognosis, and they play a key regulatory role in tumor progression by activating signaling pathways such as ERK, MAPK, Wnt, and MEK, as well as promoting epithelial-mesenchymal transition.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Hebei Province Xingtai People's Hospital Postdoctoral Workstation, Xingtai, China.
- Postdoctoral Mobile Station, Hebei Medical University, Shijiazhuang, China.
- Department of Pulmonary and Critical Care Medicine, Affiliated Xing Tai People Hospital of Hebei Medical University, Xingtai, China.
- The First Department of Pulmonary and Critical Care Medicine, The Second Hospital of Hebei Medical University, Shijiazhuang, China.
- Department of surgery, Affiliated Xing Tai People Hospital of Hebei Medical University, Xingtai, China.
Zitieren
APA
Zhang, S., Cai, Z., & Li, H. (2023). AHNAKs roles in physiology and malignant tumors. Frontiers in Oncology, 13. https://doi.org/10.3389/fonc.2023.1258951
Vancouver
Zhang S, Cai Z, Li H. AHNAKs roles in physiology and malignant tumors. Frontiers in Oncology. 2023;13. doi:10.3389/fonc.2023.1258951
BibTeX
@article{Zhang2023,
author = {Zhang, Shusen and Cai, Zhigang and Li, Hui},
title = {AHNAKs roles in physiology and malignant tumors},
journal = {Frontiers in Oncology},
year = {2023},
volume = {13},
doi = {10.3389/fonc.2023.1258951}
}
EUVIMED